| ²é¿´: 1998 | »Ø¸´: 4 | ||
zj312ͳæ (ÕýʽдÊÖ)
|
[ÇóÖú]
ÅÁÈðÎô²¼ÄÆÔÑÐרÀûÔõô²é ÒÑÓÐ1È˲ÎÓë
|
|
¸÷λ´óϺ£º ÓÐËÄܸæËßÎÒÅÁÈðÎô²¼ÄÆÔÑÐרÀûÔõô²é£¬»òÕ߸æËßÎÒËüµÄרÀûºÅ£¬½¹ÂÇÖС¡£¬Ð»Ð»£¡ |
» ²ÂÄãϲ»¶
WoSÒ»ÇøFrontiers in Genome Editing»ùÒò±à¼·½·¨ÓëÓ¦Ó÷½ÏòרÌâÑû¸å£¨Ó°ÏìÒò×Ó4.9£©
ÒѾÓÐ0È˻ظ´
WoSÒ»ÇøFrontiers in Genome Editing»ùÒò±à¼·½·¨ÓëÓ¦Ó÷½ÏòרÌâÑû¸å£¨Ó°ÏìÒò×Ó4.9£©
ÒѾÓÐ0È˻ظ´
Ò©ÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ52È˻ظ´
Óг¥Ç󳦶¾ËصĴàÈõÄâ¸Ë¾ú£¨ETBF£©
ÒѾÓÐ0È˻ظ´
¹òÇóÒ»Ö§AAV293ϸ°û
ÒѾÓÐ1È˻ظ´
²©µ¼ÍƼö
ÒѾÓÐ2È˻ظ´
ÄÄÀï×ö¸Ê°±ËáÊÜÌåÓëÅäÌå½áºÏÂʵÄÊÔÑé
ÒѾÓÐ0È˻ظ´
¹ØÓÚSCIÔÓÖ¾·¢±í¹ÒÃû
ÒѾÓÐ32È˻ظ´
ÁèÓîÀ׳Ø
³¬¼¶°æÖ÷ (ÎÄѧ̩¶·)
Сľ³æ¿ÆÑдóʹ\(^o^)/~
- DRDEPI: 1
- Ó¦Öú: 758 (²©ºó)
- ¹ó±ö: 161.802
- ½ð±Ò: 301183
- É¢½ð: 91930
- ºì»¨: 1119
- ɳ·¢: 3434
- Ìû×Ó: 93050
- ÔÚÏß: 54969.6Сʱ
- ³æºÅ: 659100
- ×¢²á: 2008-11-21
- ÐÔ±ð: GG
- רҵ: ÉúÎﻯѧ
- ¹ÜϽ: ¿ÆÑÐÉú»îÇø
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
zj312: ½ð±Ò+5, ¡ïÓаïÖú, thanks 2015-11-19 09:53:37
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
zj312: ½ð±Ò+5, ¡ïÓаïÖú, thanks 2015-11-19 09:53:37
|
¹«¿ªºÅ רÀûÃû³Æ רÀûÀàÐÍ ÉêÇëÈÕÆÚ ·¨ÂÉ״̬ WO2005065684A1 Metal salts of parecoxib as prodrugs of the COX-2 inhibitor valdecoxib for the treatment of inflammation, pain and/or fever »¯ºÏÎï רÀû 2004-12-13 WIPO INFORMATION: WITHDRAWN IN NATIONAL OFFICE WO2004004833A1 USE OF CYCLOOXYGENASE »¯ºÏÎï רÀû 2003-06-30 WIPO INFORMATION: WITHDRAWN IN NATIONAL OFFICE WO2003078433A1 Process for preparing crystalline form i of cabergoline »¯ºÏÎï רÀû 2003-03-10 - CN1216043A ×÷ΪCOX£2ÒÖÖÆ¼ÁǰҩµÄÈ¡´úµÄ±½»Çõ£°·ÑÜÉúÎï »¯ºÏÎï רÀû 1997-04-11 ÊÚȨ WO2003101441A1 Monotherapy for the treatment of amyotrophic lateral sclerosis with cyclooxygenase-2 (COX-2) inhibitor(s) ÐÂÓÃ; רÀû 2003-05-28 WIPO INFORMATION: WITHDRAWN IN NATIONAL OFFICE WO2003101438A1 Treatment for human papillomavirus ÐÂÓÃ; רÀû 2003-05-23 - WO2003088959 TREATMENT OF PARKINSON'S DISEASE WITH CYCLOOXYGENASE-2 (COX 2) INHIBITOR(S) ÐÂÓÃ; רÀû 2003-04-14 REQUEST FOR PRELIMINARY EXAMINATION FILED PRIOR TO EXPIRATION OF 19TH MONTH FROM PRIORITY DATE (PCT APPLICATION FILED BEFORE 20040101) WO2003088959A2 Monotherapy for the treatment of Parkinson's disease with cyclooxygenase-2 (COX-2) inhibitor(s) ÐÂÓÃ; רÀû 2003-04-14 REQUEST FOR PRELIMINARY EXAMINATION FILED PRIOR TO EXPIRATION OF 19TH MONTH FROM PRIORITY DATE (PCT APPLICATION FILED BEFORE 20040101) WO2003088959A3 Monotherapy for the treatment of Parkinson's disease with cyclooxygenase-2 (COX-2) inhibitor(s) ÐÂÓÃ; רÀû 2003-04-14 REQUEST FOR PRELIMINARY EXAMINATION FILED PRIOR TO EXPIRATION OF 19TH MONTH FROM PRIORITY DATE (PCT APPLICATION FILED BEFORE 20040101) CN1658853A Óû·Ñõ»¯Ã¸£2(COX 2)ÒÖÖÆ¼ÁÖÎÁƼ¡Î®ËõÐÔ¼¹Ëè²àË÷Ó²»¯Ö¢µÄµ¥Ò©ÁÆ·¨ ÐÂÓÃ; רÀû 2003-05-28 ·¢Ã÷רÀûÉêÇ빫²¼ºóµÄÊÓΪ³·»Ø |

2Â¥2015-11-18 23:46:32
ÁèÓîÀ׳Ø
³¬¼¶°æÖ÷ (ÎÄѧ̩¶·)
Сľ³æ¿ÆÑдóʹ\(^o^)/~
- DRDEPI: 1
- Ó¦Öú: 758 (²©ºó)
- ¹ó±ö: 161.802
- ½ð±Ò: 301183
- É¢½ð: 91930
- ºì»¨: 1119
- ɳ·¢: 3434
- Ìû×Ó: 93050
- ÔÚÏß: 54969.6Сʱ
- ³æºÅ: 659100
- ×¢²á: 2008-11-21
- ÐÔ±ð: GG
- רҵ: ÉúÎﻯѧ
- ¹ÜϽ: ¿ÆÑÐÉú»îÇø
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
|
¹«¿ªºÅ רÀûÃû³Æ רÀûȨÈË ÉêÇë¹ú¼Ò£¨Í¾¾¶£© ÉêÇëºÅ ÉêÇëÈÕÆÚ ·¨ÂÉ״̬ µ½ÆÚʱ¼ä CN1216043A ×÷ΪCOX£2ÒÖÖÆ¼ÁǰҩµÄÈ¡´úµÄ±½»Çõ£°·ÑÜÉúÎï - Öйú CN97193747 1997-04-11 ÊÚȨ 2017-04-11 WO2004004833A1 USE OF CYCLOOXYGENASE - PCT PCT/US2003/020558 2003-06-30 WIPO INFORMATION: WITHDRAWN IN NATIONAL OFFICE - WO2003078433A1 Process for preparing crystalline form i of cabergoline »ÔÈðÖÆÒ© PCT PCT/EP2003/002628 2003-03-10 - - WO2005065684A1 Metal salts of parecoxib as prodrugs of the COX-2 inhibitor valdecoxib for the treatment of inflammation, pain and/or fever »ÔÈðÖÆÒ© PCT PCT/IB2004/004203 2004-12-13 WIPO INFORMATION: WITHDRAWN IN NATIONAL OFFICE - |

3Â¥2015-11-18 23:49:15
Jngxq
ľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 119 (¸ßÖÐÉú)
- ½ð±Ò: 2719.5
- É¢½ð: 81
- ºì»¨: 86
- Ìû×Ó: 1630
- ÔÚÏß: 676.6Сʱ
- ³æºÅ: 2440310
- ×¢²á: 2013-04-28
- ÐÔ±ð: GG
- רҵ: Ò©¼Áѧ
4Â¥2015-11-18 23:53:34
ÂþÑ©&µ¤
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 7 (Ó×¶ùÔ°)
- ½ð±Ò: 20.3
- É¢½ð: 5
- Ìû×Ó: 34
- ÔÚÏß: 7.1Сʱ
- ³æºÅ: 4222695
- ×¢²á: 2015-11-16
5Â¥2015-11-19 13:55:24














»Ø¸´´ËÂ¥

ÊäÈëÅÁÈðÎô²¼ÄÆÔÑÐ@http://db.yaozh.com/¾ÍÄܲ鵽£¬²»¹ýÐèҪע²á³ÉΪVIP
10